What is the difference between domestic "rocket heart" artificial heart and different artificial heart?

According to the reporter , The State Drug Administration in 7 month 13 Approved by aerospace Taixin Technology Co., Ltd “ Implantable left ventricular assist system ” Innovative product registration application . This one is purely domestic “ Artificial heart ” The listing of reflects the current hot heart failure equipment track , Capital is pouring in , Constantly promote the research and development of new products .

This time, the products of aerospace Taixin have been approved for transitional treatment before heart transplantation or restoration of heart function . This product is the first implantable left ventricular assist system with magnetic suspension technology in China , Completely made in China , Own independent intellectual property rights .

  Rocket heart “ Artificial heart ”

According to introducing , Aerospace Taixin is the third approved artificial heart in China . Before that , Yongrenxin medical has been introduced from Japan EVAHEART Yongrenxin 、 Made by Suzhou Tongxin medical CH-VAD Approved by the food and drug administration .

Although it is the latest third-generation non-contact centrifugal pump , But the three products are slightly different . The biggest difference is the length of time approved . Only EVAHEART Yongrenxin is approved to be used for long-term assistance , The other two products are only approved for transitional or short-term treatment . therefore , When choosing artificial heart , The purpose of the patient should be considered , If it is only used for a few months, one or two years of transition and short-term treatment , Finally, we need to switch to heart transplantation , You can choose from all three products . But if it is for long-term or lifelong use , You should choose yongrenxin with long-term treatment indications EVAHEART.

  chart ： Yongrenxin EVAHEART It is the only artificial heart approved for long-term treatment

Experts say , The three products are the third generation non-contact centrifugal pumps . The applied technology is different , Yongrenxin uses Japanese hydraulic suspension technology , Tongxin uses domestic magnetic levitation technology , The rocket core uses domestic magnetic fluid suspension technology . Different technology , Maturity and security are also different . Of the three products , Only yongrenxin is in China 、 Japan 、 Europe has obtained listing approval , Get... In the United States FDA Licensed for patient treatment . in addition , The longest use time of yongrenxin overseas patients has reached 11 year , Clinical trials in China 1 The annual survival rate has reached 100%, These factors make yongrenxin recognized by experts from the food and drug administration , Approved long-term assistance .

At present, artificial heart mainly refers to left ventricular assist device , It is used to pump blood from the left ventricle into the ascending aorta , Assist in cardiac work , Therefore, it is often called “ Artificial heart ”. current “ Artificial heart ” It mainly assists the heart , Instead of completely replacing the role of the heart , Some patients can recover their cardiac function after using left ventricular assist devices , After recovery, remove the artificial heart and resume normal life . Compared with heart transplantation , Artificial heart does not need to take anti rejection drugs for a long time , Daily maintenance costs less .